BAXALTA Trademark

Trademark Overview


On Tuesday, May 12, 2015, a trademark application was filed for BAXALTA with the United States Patent and Trademark Office. The USPTO has given the BAXALTA trademark a serial number of 79171327. The federal status of this trademark filing is PARTIAL SECTION 71 ACCEPTED as of Friday, February 24, 2023. This trademark is owned by Baxalta Incorporated. The BAXALTA trademark is filed in the Pharmaceutical Products, Medical Instrument Products, and Education & Entertainment Services categories with the following description:

[ Education and training services, namely, providing classes, seminars, conferences, lectures and workshops in the fields of pharmaceuticals, health care, health insurance, medical information, bleeding disorders or conditions, hemophilia, hematology, immunology, oncology and patient care; education services, namely, providing printed publications in the nature of newsletters and white papers in the field of hemophilia; provision of information for training and teaching relating to pharmaceuticals, health care, health insurance, medical information, bleeding disorders or conditions, hemophilia, hematology, immunology, oncology and patient care; provision of non-downloadable electronic publications, namely, newsletters, articles, brochures and booklets in the field of pharmaceuticals, health care, health insurance, medical information, bleeding disorders or conditions, hemophilia, hematology, immunology, oncology and patient care ]

Pharmaceutical preparations, substances and products for the treatment of blood diseases and disorders, immuno deficiency disorders, cancer; pharmaceuticals for the treatment of blood diseases and disorders, immuno deficiency disorders, cancer; pharmaceutical preparations, namely, proteinase inhibitors in the nature of alpha-1 proteinase inhibitors; pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders, all containing immune globulin infusion (human) and recombinant human hyaluronidase; reconstitution assembly sold containing vials prefilled with pharmaceutical preparations for the treatment of blood diseases and disorders; normal serum albumin (human) solution for intravenous administration; im...

Medical devices, namely, devices for reconstituting dried pharmaceuticals; medical apparatus and instruments, namely, medical infusion set for subcutaneous delivery of pharmaceuticals; medical apparatus for the preparation and parental infusion of pharmaceutical preparations
baxalta

General Information


Serial Number79171327
Word MarkBAXALTA
Filing DateTuesday, May 12, 2015
Status707 - PARTIAL SECTION 71 ACCEPTED
Status DateFriday, February 24, 2023
Registration Number5084124
Registration DateTuesday, November 22, 2016
Mark Drawing3000 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, February 16, 2016

Trademark Statements


Goods and Services[ Education and training services, namely, providing classes, seminars, conferences, lectures and workshops in the fields of pharmaceuticals, health care, health insurance, medical information, bleeding disorders or conditions, hemophilia, hematology, immunology, oncology and patient care; education services, namely, providing printed publications in the nature of newsletters and white papers in the field of hemophilia; provision of information for training and teaching relating to pharmaceuticals, health care, health insurance, medical information, bleeding disorders or conditions, hemophilia, hematology, immunology, oncology and patient care; provision of non-downloadable electronic publications, namely, newsletters, articles, brochures and booklets in the field of pharmaceuticals, health care, health insurance, medical information, bleeding disorders or conditions, hemophilia, hematology, immunology, oncology and patient care ]
Description of MarkThe mark consists of the word "BAXALTA" with light rays emanating from the center of the letter "X".
Goods and ServicesPharmaceutical preparations, substances and products for the treatment of blood diseases and disorders, immuno deficiency disorders, cancer; pharmaceuticals for the treatment of blood diseases and disorders, immuno deficiency disorders, cancer; pharmaceutical preparations, namely, proteinase inhibitors in the nature of alpha-1 proteinase inhibitors; pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders, all containing immune globulin infusion (human) and recombinant human hyaluronidase; reconstitution assembly sold containing vials prefilled with pharmaceutical preparations for the treatment of blood diseases and disorders; normal serum albumin (human) solution for intravenous administration; immunoglobulin for parenteral, intramuscular and intravenous administration to humans; antihemophilic factor for intravenous administration in humans; antihemophilic factor recombinant; pharmaceutical preparations, namely, chemotherapeutic agents
Indication of Colors claimedColor is not claimed as a feature of the mark.
Goods and ServicesMedical devices, namely, devices for reconstituting dried pharmaceuticals; medical apparatus and instruments, namely, medical infusion set for subcutaneous delivery of pharmaceuticals; medical apparatus for the preparation and parental infusion of pharmaceutical preparations

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateWednesday, September 2, 2015
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class010 - Surgical, medical, dental, and veterinary apparatus and instruments, artificial limbs, eyes, and teeth; orthopedic articles; suture materials.
US Class Codes026, 039, 044
Class Status Code6 - Active
Class Status DateWednesday, September 2, 2015
Primary Code010
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class041 - Education; providing of training; entertainment; sporting and cultural activities.
US Class Codes100, 101, 107
Class Status CodeG - NOT AVAILABLE
Class Status DateFriday, February 24, 2023
Primary Code041
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameBaxalta Incorporated
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressBannockburn, IL 60015

Party NameBaxalta Incorporated
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressBannockburn, IL 60015

Party NameBaxalta Incorporated
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressBannockburn, IL 60015

Trademark Events


Event DateEvent Description
Monday, November 20, 2023PARTIAL INVALIDATION PROCESSED BY THE IB
Thursday, October 26, 2023PARTIAL INVALIDATION OF REG EXT PROTECTION SENT TO IB
Thursday, October 26, 2023INVALIDATION PROCESSED
Tuesday, October 24, 2023PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED
Friday, February 24, 2023NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED
Friday, February 24, 2023REGISTERED - PARTIAL SEC 71 ACCEPTED
Friday, February 24, 2023CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Saturday, October 22, 2022NEW REPRESENTATIVE AT IB RECEIVED
Friday, October 21, 2022NEW REPRESENTATIVE AT IB RECEIVED
Monday, August 22, 2022TEAS SECTION 71 RECEIVED
Monday, November 22, 2021COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
Saturday, March 25, 2017FINAL DECISION TRANSACTION PROCESSED BY IB
Tuesday, March 7, 2017FINAL DISPOSITION NOTICE SENT TO IB
Tuesday, March 7, 2017FINAL DISPOSITION PROCESSED
Wednesday, February 22, 2017FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Tuesday, November 22, 2016REGISTERED-PRINCIPAL REGISTER
Thursday, September 15, 2016ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Thursday, September 15, 2016TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Friday, July 1, 2016EXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED
Wednesday, March 16, 2016EXTENSION OF TIME TO OPPOSE RECEIVED
Tuesday, February 16, 2016CHANGES/CORRECTIONS AFTER PUB APPROVAL ENTERED
Tuesday, February 16, 2016OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, February 16, 2016PUBLISHED FOR OPPOSITION
Saturday, February 13, 2016NOTIFICATION PROCESSED BY IB
Friday, February 5, 2016ASSIGNED TO PETITION STAFF
Wednesday, January 27, 2016NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Wednesday, January 27, 2016NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Wednesday, January 27, 2016NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Monday, January 18, 2016TEAS POST PUBLICATION AMENDMENT RECEIVED
Tuesday, January 12, 2016LAW OFFICE PUBLICATION REVIEW COMPLETED
Tuesday, January 5, 2016APPROVED FOR PUB - PRINCIPAL REGISTER
Friday, December 18, 2015TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, December 18, 2015CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, December 18, 2015APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Friday, December 18, 2015ASSIGNED TO LIE
Friday, December 4, 2015TEAS RESPONSE TO OFFICE ACTION RECEIVED
Thursday, November 19, 2015ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Thursday, November 19, 2015TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Friday, September 25, 2015REFUSAL PROCESSED BY IB
Tuesday, September 8, 2015NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Tuesday, September 8, 2015REFUSAL PROCESSED BY MPU
Tuesday, September 8, 2015APPLICATION FILING RECEIPT MAILED
Sunday, September 6, 2015NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Saturday, September 5, 2015NON-FINAL ACTION WRITTEN
Wednesday, September 2, 2015ASSIGNED TO EXAMINER
Wednesday, September 2, 2015NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, August 27, 2015SN ASSIGNED FOR SECT 66A APPL FROM IB